Journey of CAR T‑cells: Emphasising the concepts and advancements in breast cancer (Review).
Kausar MA, Anwar S, El-Horany HE, Khan FH, Tyagi N, Najm MZ, Sadaf, Eisa AA, Dhara C, Gantayat S.
Kausar MA, et al.
Int J Oncol. 2023 Dec;63(6):130. doi: 10.3892/ijo.2023.5578. Epub 2023 Oct 13.
Int J Oncol. 2023.
PMID: 37830150
Free PMC article.
Review.
Genetically modified T-lymphocytic cells have emerged as a novel therapeutic approach for the treatment of solid tumours, haematological malignancies, and relapsed/refractory B-lymphocyte malignancies as a result of recent clinical trial findings; the treatment is referred …
Genetically modified T-lymphocytic cells have emerged as a novel therapeutic approach for the treatment of solid tumours, haematological mal …